| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |